Balaxi Pharmaceuticals Limited reported no deviation in the utilization of funds raised through a preferential issue totaling Rs. 47,56,92,250 for the quarter ending June 30, 2025, pursuant to Regulation 32.
AI Assistant
Balaxi Pharmaceuticals Ltd
2025
Announcement
Find Answers
Ask about any part of the document to get insights, explanations, or key details.